Congenital hyperinsulinism in infancy and childhood: challenges, unmet needs and the perspective of patients and families

Abstract excerpt

BACKGROUND: Congenital hyperinsulinism (CHI) is the most common cause of persistent hypoglycemia in infants and children, and carries a considerable risk of neurological damage and developmental delays if diagnosis and treatment are delayed. Despite rapid advances in diagnosis and management, long-term developmental outcomes have not significantly improved in the past years. CHI remains a disease that is...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Diabetes Management and Research
• Share to Growth Hormone and Insulin-like Growth Factors
• Share to Hyperglycemia and glycemic control in critically ill and hospitalized patients